DMK PHARMACEUTICALS Corp: M&A transaction — Adamis Pharmaceuticals closes sale of Conway, AR property for $2M to FarmaKeio Pharmacy Network

DMK PHARMACEUTICALS Corp

Sold building, real property, equipment, and IP for $2M cash before estimated fees of ~$232,700.
Buyer is unaffiliated third party FarmaKeio Pharmacy Network, LLC.
Property formerly used by discontinued compounding pharmacy business.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.95

DMK PHARMACEUTICALS Corp completed a disposition involving FarmaKeio Pharmacy Network, LLC for $2,000,000, before commissions, fees and closing costs estimated at approximately $232,700 (closed 2023-07-25).

Action: disposition
Counterparty: FarmaKeio Pharmacy Network, LLC
Consideration: $2,000,000, before commissions, fees and closing costs estimated at approximately $232,700
Closing: 2023-07-25

Exact text from the filing

we sold the building, real property, personal property, equipment and related assets. The total aggregate consideration for the sale of the real property and other assets was $2,000,000, before commissions, fees and closing costs estimated at approximately $232,700. The Agreement includes a number customary provisions addressing matters such as title and title

View on SEC.gov

Browse all m&a transactions →

Source: SEC EDGAR

accession 0001387131-23-009113

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.